Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions.
about
Cabozantinib in metastatic renal cell carcinoma: latest findings and clinical potential.Cabozantinib-induced osteoblast secretome promotes survival and migration of metastatic prostate cancer cells in bone.Modulation of cabozantinib efficacy by the prostate tumor microenvironment.Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer.Cabozantinib Affects Osteosarcoma Growth Through A Direct Effect On Tumor Cells and Modifications In Bone Microenvironment.Paeoniflorin regulates osteoclastogenesis and osteoblastogenesis via manipulating NF-κB signaling pathway both in vitro and in vivo.Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts.
P2860
Q42257155-00411952-E949-4920-81C1-FC02A81B795CQ44676922-DA684CE4-EDCC-41FB-9FA0-186A61594390Q46493299-6112012C-8770-4EE7-B9C1-0E0CE7E97D79Q47563547-2D3D6698-13C4-4E41-8703-78E40D3B1FC1Q52665713-9B273BB9-2C4E-4549-8AC6-065ACEB65DF2Q55344415-4BC79120-9996-43C9-94A3-42F7A3B6DD9FQ55474543-0E47FC0C-C2CB-4A25-9234-2BD159A08E03
P2860
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Cabozantinib targets bone micr ...... last and osteoblast functions.
@en
Cabozantinib targets bone micr ...... last and osteoblast functions.
@nl
type
label
Cabozantinib targets bone micr ...... last and osteoblast functions.
@en
Cabozantinib targets bone micr ...... last and osteoblast functions.
@nl
prefLabel
Cabozantinib targets bone micr ...... last and osteoblast functions.
@en
Cabozantinib targets bone micr ...... last and osteoblast functions.
@nl
P2093
P2860
P356
P1433
P1476
Cabozantinib targets bone micr ...... clast and osteoblast functions
@en
P2093
Antonio Russo
Bruno Vincenzi
Daniele Santini
Francesco Pantano
Giulia Ribelli
Giuseppe Tonini
Marco Fioramonti
Michele Iuliani
Nicola Papapietro
Vincenzo Denaro
P2860
P304
20113-20121
P356
10.18632/ONCOTARGET.15390
P407
P577
2017-03-01T00:00:00Z